EULAR SSc Recommendations Now Include Immunosuppressants
The update to 2017 recommendations include targeted synthetic and biologic disease-modifying antirheumatic drugs for the first time.
Source: medscape.com
Stay updated with breaking news from Scleroderma Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The update to 2017 recommendations include targeted synthetic and biologic disease-modifying antirheumatic drugs for the first time.